PubRank

G Assmann

Author PubWeight™ 308.56‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1. Nat Genet 1999 7.04
2 Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA 2005 5.60
3 The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol 2007 3.81
4 Apolipoprotein E polymorphism and coronary artery disease. Arteriosclerosis 1983 2.37
5 The molecular pathology of lecithin:cholesterol acyltransferase (LCAT) deficiency syndromes. J Lipid Res 1997 2.14
6 High density lipoproteins and arteriosclerosis. Role of cholesterol efflux and reverse cholesterol transport. Arterioscler Thromb Vasc Biol 2001 2.03
7 KCNE1 mutations cause jervell and Lange-Nielsen syndrome. Nat Genet 1997 1.90
8 Mutagenically separated PCR (MS-PCR): a highly specific one step procedure for easy mutation detection. Nucleic Acids Res 1993 1.85
9 Lipoprotein(a) further increases the risk of coronary events in men with high global cardiovascular risk. J Am Coll Cardiol 2001 1.80
10 Multicentre study of a new enzymatic method of cholesterol determination. J Clin Chem Clin Biochem 1984 1.77
11 Lipoprotein(a) is an independent risk factor for myocardial infarction at a young age. Clin Chem 1990 1.75
12 A molecular defect causing fish eye disease: an amino acid exchange in lecithin-cholesterol acyltransferase (LCAT) leads to the selective loss of alpha-LCAT activity. Proc Natl Acad Sci U S A 1991 1.69
13 C-reactive protein and the severity of atherosclerosis in myocardial infarction patients with stable angina pectoris. Eur Heart J 2000 1.63
14 Defective peroxisomal catabolism of branched fatty acyl coenzyme A in mice lacking the sterol carrier protein-2/sterol carrier protein-x gene function. Genes Dev 1998 1.58
15 A novel frameshift mutation in PMP22 accounts for hereditary neuropathy with liability to pressure palsies. Neurology 1997 1.56
16 Fibrinogen and factor VII in the prediction of coronary risk. Results from the PROCAM study in healthy men. Arterioscler Thromb 1994 1.52
17 Swine lipoproteins and atherosclerosis. Changes in the plasma lipoproteins and apoproteins induced by cholesterol feeding. Biochemistry 1975 1.50
18 Comparison of prostate-specific antigen (PSA) measured by four combinations of free PSA and total PSA assays. Clin Chem 1997 1.50
19 Hemostasis in normotensive and hypertensive men: results of the PROCAM study. The prospective cardiovascular Münster study. J Hypertens 1998 1.48
20 D-dimers in relation to the severity of arteriosclerosis in patients with stable angina pectoris after myocardial infarction. Eur Heart J 1999 1.48
21 Association of the GPIa C807T and GPIIIa PlA1/A2 polymorphisms with premature myocardial infarction in men. Eur Heart J 2002 1.47
22 Genotypic interaction and gender specificity of common genetic variants in the p53/mdm2 network in Crohn's disease. Digestion 2010 1.45
23 Quantification of high-density-lipoprotein cholesterol by precipitation with phosphotungstic acid/MgCl2. Clin Chem 1983 1.45
24 Plasminogen activator inhibitor-1 4G/4G-genotype is associated with cerebral sinus thrombosis in factor V Leiden carriers. Thromb Haemost 1998 1.43
25 Suppression of endothelial cell apoptosis by high density lipoproteins (HDL) and HDL-associated lysosphingolipids. J Biol Chem 2001 1.43
26 Low-density lipoproteins inhibit the Na+/H+ antiport in human platelets. A novel mechanism enhancing platelet activity in hypercholesterolemia. Circulation 1997 1.43
27 Identification of oxidized low-density lipoprotein in human serum by NMR spectroscopy. Clin Sci (Lond) 1998 1.40
28 Measurement of prostate-specific antigen: no advantage to ultrasensitive assays? J Natl Cancer Inst 1996 1.39
29 [Primary and secondary prevention of coronary heart disease. A position paper of the International Task Force for the Prevention of Coronary Heart Disease]. Dtsch Med Wochenschr 2000 1.39
30 Isolation of prostate-derived single cells and cell clusters from human peripheral blood. Cancer Res 1996 1.37
31 Systemic inflammatory parameters in patients with atherosclerosis of the coronary and peripheral arteries. Arterioscler Thromb Vasc Biol 1999 1.34
32 Hind III RFLP in the lipoprotein lipase gene, (LPL). Nucleic Acids Res 1987 1.32
33 Structural analysis of human apolipoprotein A-I variants. Amino acid substitutions are nonrandomly distributed throughout the apolipoprotein A-I primary structure. J Biol Chem 1990 1.31
34 Systematically missing confounders in individual participant data meta-analysis of observational cohort studies. Stat Med 2009 1.27
35 c-erbB-2/EGFR as dominant heterodimerization partners determine a motogenic phenotype in human breast cancer cells. FASEB J 1999 1.27
36 Risk for diabetes mellitus in middle-aged Caucasian male participants of the PROCAM study: implications for the definition of impaired fasting glucose by the American Diabetes Association. Prospective Cardiovascular Münster. J Clin Endocrinol Metab 2000 1.26
37 Pst I RFLP close to the LDL receptor gene. Nucleic Acids Res 1986 1.26
38 The rat arginine-rich apoprotein and its redistribution following injection of iodinated lipoproteins into normal and hypercholesterolemic rats. Atherosclerosis 1977 1.24
39 Phytanic acid activates the peroxisome proliferator-activated receptor alpha (PPARalpha) in sterol carrier protein 2-/ sterol carrier protein x-deficient mice. J Biol Chem 1999 1.21
40 Sterol carrier protein X is peroxisomal 3-oxoacyl coenzyme A thiolase with intrinsic sterol carrier and lipid transfer activity. J Biol Chem 1994 1.19
41 Prevention of coronary heart disease by raising high-density lipoprotein cholesterol? Curr Opin Lipidol 2000 1.18
42 Endogenous apolipoprotein E modulates cholesterol efflux and cholesteryl ester hydrolysis mediated by high-density lipoprotein-3 and lipid-free apolipoproteins in mouse peritoneal macrophages. J Mol Med (Berl) 2000 1.18
43 The LQT syndromes--current status of molecular mechanisms. Z Kardiol 1999 1.18
44 Association of apolipoprotein E polymorphism, low-density lipoprotein cholesterol, and coronary artery disease. Clin Chem 1986 1.17
45 Interaction of high density lipoproteins with cholesteryl ester-laden macrophages: biochemical and morphological characterization of cell surface receptor binding, endocytosis and resecretion of high density lipoproteins by macrophages. EMBO J 1985 1.17
46 Overexpression and accumulation of apolipoprotein E as a cause of hypertriglyceridemia. J Biol Chem 1998 1.17
47 Lipid-protein interactions in high density lipoproteins. Proc Natl Acad Sci U S A 1974 1.17
48 Site-specific methionine sulfoxide formation is the structural basis of chromatographic heterogeneity of apolipoproteins A-I, C-II, and C-III. J Lipid Res 1991 1.16
49 A frameshift mutation in the human apolipoprotein A-I gene causes high density lipoprotein deficiency, partial lecithin: cholesterol-acyltransferase deficiency, and corneal opacities. J Clin Invest 1991 1.16
50 Obesity, mortality and cardiovascular disease in the Münster Heart Study (PROCAM). Atherosclerosis 1999 1.15
51 Apolipoprotein C-III(Lys58----Glu). Identification of an apolipoprotein C-III variant in a family with hyperalphalipoproteinemia. J Clin Invest 1991 1.15
52 Genotype/phenotype relationships in HNF-4alpha/MODY1: haploinsufficiency is associated with reduced apolipoprotein (AII), apolipoprotein (CIII), lipoprotein(a), and triglyceride levels. Diabetes 2000 1.15
53 Characterization, subcellular localization, and partial purification of a heparin-released triglyceride lipase from rat liver. J Biol Chem 1973 1.14
54 Isolation and characterization of an abnormal high density lipoprotein in Tangier Diesase. J Clin Invest 1977 1.13
55 A plasma lipoprotein containing only apolipoprotein E and with gamma mobility on electrophoresis releases cholesterol from cells. Proc Natl Acad Sci U S A 1994 1.13
56 Isolation of blood-borne epithelium-derived c-erbB-2 oncoprotein-positive clustered cells from the peripheral blood of breast cancer patients. Int J Cancer 1998 1.12
57 The lipoprotein abnormality in Tangier disease: quantitation of A apoproteins. J Clin Invest 1977 1.12
58 Phytanic acid is ligand and transcriptional activator of murine liver fatty acid binding protein. J Lipid Res 1999 1.11
59 The high density lipoprotein- and apolipoprotein A-I-induced mobilization of cellular cholesterol is impaired in fibroblasts from Tangier disease subjects. Biochem Biophys Res Commun 1994 1.10
60 Effects of lovastatin on progression of non-dilated and dilated coronary segments and on restenosis in patients after PTCA. The cholesterol lowering atherosclerosis PTCA trial (CLAPT). Eur Heart J 1999 1.10
61 An intronic mutation in a lariat branchpoint sequence is a direct cause of an inherited human disorder (fish-eye disease). J Clin Invest 1996 1.08
62 Acceleration of reverse cholesterol transport. Curr Opin Cardiol 2000 1.08
63 Serum ferritin, transferrin, haptoglobin, and iron in middle- and long-distance runners, elite rowers, and professional racing cyclists. Int J Sports Med 1981 1.07
64 An improved method for quantification of cholesterol and cholesteryl esters in human monocyte-derived macrophages by high performance liquid chromatography with identification of unassigned cholesteryl ester species by means of secondary ion mass spectrometry. J Lipid Res 1997 1.07
65 Polymorphisms in the apolipoprotein AI-CIII gene complex. Mol Biol Med 1986 1.07
66 Interleukin 10 promoter microsatellite polymorphisms are associated with response to long term treatment with etanercept in patients with rheumatoid arthritis. Ann Rheum Dis 2004 1.06
67 Increased lipoprotein(a) is an important risk factor for venous thromboembolism in childhood. Circulation 1999 1.05
68 Simplified turbidimetric determination of apolipoproteins A-I, A-II and B using a microtitre method. J Clin Chem Clin Biochem 1988 1.04
69 The relationship of lipoprotein (a) (Lp(a)) to risk factors of coronary heart disease: initial results of the prospective epidemiological study on company employees in Westfalia. J Clin Chem Clin Biochem 1984 1.04
70 Aberrant oxidation of the cholesterol side chain in bile acid synthesis of sterol carrier protein-2/sterol carrier protein-x knockout mice. J Biol Chem 1999 1.04
71 Cholesterol efflux, cholesterol esterification, and cholesteryl ester transfer by LpA-I and LpA-I/A-II in native plasma. Arterioscler Thromb Vasc Biol 1995 1.03
72 A molecular model of high density lipoproteins. Proc Natl Acad Sci U S A 1974 1.02
73 Extended haplotype analysis reveals an association of TNF polymorphisms with susceptibility to systemic lupus erythematosus beyond HLA-DR3. Scand J Rheumatol 2005 1.02
74 Plasma lipoproteins and physical activity: a review. Int J Sports Med 1982 1.02
75 Physiological role and clinical relevance of high-density lipoprotein subclasses. Curr Opin Lipidol 1994 1.01
76 The human ABCG4 gene is regulated by oxysterols and retinoids in monocyte-derived macrophages. Biochem Biophys Res Commun 2001 1.01
77 Cloning, expression, and nucleotide sequence of rat liver sterol carrier protein 2 cDNAs. J Biol Chem 1991 1.01
78 Characterization of high density lipoproteins in patients heterozygous for Tangier disease. J Clin Invest 1977 1.00
79 Phenotype-dependent differences in apolipoprotein E metabolism and in cholesterol homeostasis in human monocyte-derived macrophages. J Clin Invest 1998 1.00
80 Apolipoprotein E polymorphism and hyperlipidemia. Clin Chem 1984 1.00
81 ATP binding cassette transporter ABCA1 modulates the secretion of apolipoprotein E from human monocyte-derived macrophages. FASEB J 2001 1.00
82 One-step screening method for the polymorphism of apolipoproteins A-I, A-II, and A-IV. J Lipid Res 1982 1.00
83 Effects of dietary fatty acids on the composition and oxidizability of low-density lipoprotein. Eur J Clin Nutr 2002 0.99
84 Cell-derived unesterified cholesterol cycles between different HDLs and LDL for its effective esterification in plasma. Arterioscler Thromb 1993 0.98
85 Swine aortic smooth muscle in tissue culture. Some effects of purified swine lipoproteins on cell growth and morphology. Circ Res 1976 0.98
86 Associations of obesity markers, insulin, and sex hormones with HDL-cholesterol levels in Turkish and German individuals. Atherosclerosis 1999 0.97
87 Phospholipid transfer protein mediated conversion of high density lipoproteins generates pre beta 1-HDL. Biochim Biophys Acta 1996 0.97
88 Autosomal recessive long-QT syndrome (Jervell Lange-Nielsen syndrome) is genetically heterogeneous. Hum Genet 1997 0.95
89 Tangier disease: a disorder of intracellular membrane traffic. Proc Natl Acad Sci U S A 1985 0.95
90 Association of variables of coagulation, fibrinolysis and acute-phase with atherosclerosis in coronary and peripheral arteries and those arteries supplying the brain. Thromb Haemost 1995 0.95
91 Interleukin-6 promoter polymorphism (--174 G/C) in Caucasian German patients with systemic lupus erythematosus. Rheumatology (Oxford) 2001 0.94
92 Relationship of lipoprotein(a) to variables of coagulation and fibrinolysis in a healthy population. Clin Chem 1991 0.94
93 Smoking, lipoproteins and coronary heart disease risk. Data from the Münster Heart Study (PROCAM). Eur Heart J 1998 0.94
94 Apoprotein A metabolism in Tangier disease. Atherosclerosis 1978 0.94
95 Effects of age, lipoproteins, and hemostatic parameters on the role of homocyst(e)inemia as a cardiovascular risk factor in men. Arterioscler Thromb 1994 0.94
96 Treatment goals for low-density lipoprotein cholesterol in the secondary prevention of coronary heart disease: absolute levels or extent of lowering? Am J Cardiol 1997 0.93
97 Apolipoprotein A-I variants. Naturally occurring substitutions of proline residues affect plasma concentration of apolipoprotein A-I. J Clin Invest 1989 0.93
98 Double-differential PCR for gene dosage estimation of erbB oncogenes in benign and cancer tissues and comparison to cellular DNA content. Gene 1995 0.93
99 Using mutagenic polymerase chain reaction primers to detect carriers of familial defective apolipoprotein B-100. Clin Chem 1991 0.93
100 Assignment of Tangier disease to chromosome 9q31 by a graphical linkage exclusion strategy. Nat Genet 1998 0.93
101 A unique genetic and biochemical presentation of fish-eye disease. J Clin Invest 1995 0.93
102 Suppression of endogenous testosterone in young men increases serum levels of high density lipoprotein subclass lipoprotein A-I and lipoprotein(a). J Clin Endocrinol Metab 1997 0.92
103 Regulation of high density lipoprotein receptors in cultured macrophages: role of acyl-CoA:cholesterol acyltransferase. EMBO J 1985 0.92
104 Relationship between plasma viscosity and the severity of coronary heart disease. Arterioscler Thromb Vasc Biol 1998 0.91
105 High density lipoproteins induce cell cycle entry in vascular smooth muscle cells via mitogen activated protein kinase-dependent pathway. Thromb Haemost 2001 0.91
106 Characterization of the oligosaccharide side chain of apolipoprotein C-III from human plasma very low density lipoproteins. Biochim Biophys Acta 1978 0.91
107 Heterozygosity for lysosomal acid lipase E8SJM mutation and serum lipid concentrations. Nutr Metab Cardiovasc Dis 2012 0.90
108 Effects of the apolipoprotein E polymorphism on uptake and transfer of cell-derived cholesterol in plasma. J Clin Invest 1995 0.90
109 Metabolism of sphingosine bases. XV. Enzymatic degradation of 4t-sphingenine 1-phosphate (sphingosine 1-phosphate) to 2t-hexadecen-1-al and ethanolamine phosphate. Hoppe Seylers Z Physiol Chem 1970 0.90
110 Topography and dynamics of receptors for acetylated and malondialdehyde-modified low-density lipoprotein in the plasma membrane of mouse peritoneal macrophages as visualized by colloidal gold in conjunction with surface replicas. J Histochem Cytochem 1984 0.90
111 Factor V Leiden mutation is a risk factor for cerebral venous thrombosis: a case-control study of 55 patients. Stroke 1998 0.90
112 Plasma Lp(a) levels correlate with number, severity, and length-extension of coronary lesions in male patients undergoing coronary arteriography for clinically suspected coronary atherosclerosis. Arterioscler Thromb 1994 0.89
113 [Obesity and cardiovascular risk]. Herz 2001 0.89
114 An ecological study of determinants of coronary heart disease rates: a comparison of Czech, Bavarian and Israeli men. Int J Epidemiol 1999 0.89
115 Bst NI (Eco RII) RFLP in the lipoprotein lipase gene (LPL). Nucleic Acids Res 1988 0.89
116 A quantitative densitometric method for the rapid separation and quantitation of the major tissue and lipoprotein lipids by high-performance thin-layer chromatography. I. Sample preparation, chromatography, and densitometry. J Chromatogr 1984 0.89
117 Deletion polymorphism 5' to the human apolipoprotein AI (apo AI) gene. Nucleic Acids Res 1986 0.89
118 Reverse cholesterol transport in plasma of patients with different forms of familial HDL deficiency. Arterioscler Thromb Vasc Biol 1995 0.88
119 HDL3-mediated inhibition of thrombin-induced platelet aggregation and fibrinogen binding occurs via decreased production of phosphoinositide-derived second messengers 1,2-diacylglycerol and inositol 1,4,5-tris-phosphate. Arterioscler Thromb Vasc Biol 1998 0.88
120 Tangier disease: defective recombination of a specific Tangier apolipoprotein A-I isoform (pro-apo A-i) with high density lipoproteins. Proc Natl Acad Sci U S A 1983 0.88
121 LDL-cholesterol determination in blood serum following precipitation of LDL with polyvinylsulfate. Clin Chim Acta 1984 0.88
122 The Münster Heart Study (PROCAM): total mortality in middle-aged men is increased at low total and LDL cholesterol concentrations in smokers but not in nonsmokers. Circulation 1997 0.88
123 Prevalence of factor V Leiden mutation in young adults with cerebral ischaemia: a case-control study on 225 patients. J Neurol 1998 0.88
124 Molecular analysis at the Harvey Ras-1 gene in patients with long QT syndrome. J Mol Med (Berl) 1995 0.88
125 Structure-activity studies of human sterol carrier protein 2. J Biol Chem 1994 0.87
126 Compound heterozygosity for a structural apolipoprotein A-I variant, apo A-I(L141R)Pisa, and an apolipoprotein A-I null allele in patients with absence of HDL cholesterol, corneal opacifications, and coronary heart disease. Circulation 1996 0.87
127 International consensus statement on olive oil and the Mediterranean diet: implications for health in Europe. The Olive Oil and the Mediterranean Diet Panel. Eur J Cancer Prev 1997 0.87
128 Genomic sequence and structure of the human ABCG1 (ABC8) gene. Biochem Biophys Res Commun 2001 0.87
129 Adenosine(5') oligophospho-(5') guanosines and guanosine(5') oligophospho-(5') guanosines in human platelets. J Clin Invest 1998 0.87
130 Multicenter evaluation of a homogeneous assay for HDL-cholesterol without sample pretreatment. Clin Chem 1997 0.87
131 Low-dose expression of a human apolipoprotein E transgene in macrophages restores cholesterol efflux capacity of apolipoprotein E-deficient mouse plasma. Proc Natl Acad Sci U S A 1998 0.87
132 High density lipoprotein infusion and partial plasma exchange in Tangier disease. Eur J Clin Invest 1978 0.86
133 The low down on lipoprotein lipase. Nat Genet 1995 0.86
134 Human apolipoprotein A-I polymorphism. Identification of amino acid substitutions in three electrophoretic variants of the Münster-3 type. J Biol Chem 1984 0.86
135 The effects of cigarette smoking on serum levels of HDL cholesterol and HDL apolipoprotein A-I. Findings of a prospective epidemiological study on employees of several companies in Westphalia, West Germany. J Clin Chem Clin Biochem 1984 0.86
136 [Knowledge about stroke among the German population]. Dtsch Med Wochenschr 2000 0.86
137 Fatal genetic defect causing Wolman disease. J Inherit Metab Dis 1999 0.86
138 New case of apoprotein C-II deficiency. Lancet 1980 0.86
139 Homozygosity for a splice junction mutation in exon 8 of the gene encoding lysosomal acid lipase in a Spanish kindred with cholesterol ester storage disease (CESD). Hum Genet 1995 0.85
140 Arterial and venous cytokine response to cardiopulmonary bypass for low risk CABG and relation to hemodynamics. Eur J Cardiothorac Surg 1995 0.85
141 Plasma and fibroblasts of Tangier disease patients are disturbed in transferring phospholipids onto apolipoprotein A-I. J Lipid Res 1998 0.85
142 Metabolism of sphingosine bases. 13. Enzymatic synthesis of 1-phosphate esters of 4t-sphingenine (sphingosine), sphinganine (dihydrosphingosine), 4-hydroxysphinganine (phytosphingosine) and 3-dehydrosphinganine by erythrocytes. Hoppe Seylers Z Physiol Chem 1970 0.85
143 Coagulation factor VII and the risk of coronary heart disease in healthy men. Arterioscler Thromb Vasc Biol 1997 0.85
144 Activation of phosphatidylinositol-specific phospholipase C by HDL-associated lysosphingolipid. Involvement in mitogenesis but not in cholesterol efflux. Biochemistry 2000 0.85
145 Electrophoretic screening for genetic variation in apolipoprotein C-III: identification of a novel apoC-III variant, apoC-III(Asp45-->Asn), in a Turkish patient. J Lipid Res 1994 0.85
146 Management of hypertriglyceridemic patients. A. Treatment classifications and goals. Am J Cardiol 1991 0.85
147 Dyslipidaemia and cardiovascular risk in diabetes. Diabetes Obes Metab 1999 0.85
148 The replacement of arginine by cysteine at residue 151 in apolipoprotein A-I produces a phenotype similar to that of apolipoprotein A-IMilano. Atherosclerosis 1997 0.85
149 A novel missense (E163G) mutation in the catalytic subunit of lipoprotein lipase causes familial chylomicronemia. Hum Mutat 1996 0.85
150 Failure to confirm ferritin and caeruloplasmin as risk factors for the angiographic extent of coronary arteriosclerosis. Coron Artery Dis 1998 0.85
151 Plasma fibrinogen in relation to the severity of arteriosclerosis in patients with stable angina pectoris after myocardial infarction. Coron Artery Dis 2001 0.85
152 Cloning and sequencing of a novel murine liver carboxylesterase cDNA. Biochim Biophys Acta 1998 0.85
153 Accumulation of cardiolipin and lysocardiolipin in fibroblasts from Tangier disease subjects. FEBS Lett 2001 0.85
154 Differential secretion of atrial and brain natriuretic peptide in critically ill patients. Anesth Analg 2001 0.85
155 NMR determination of the secondary structure and the three-dimensional polypeptide backbone fold of the human sterol carrier protein 2. FEBS Lett 1993 0.84
156 Atherosclerosis in apolipoprotein E-deficient mice is decreased by the suppression of endogenous sex hormones. Horm Metab Res 2001 0.84
157 31P nuclear magnetic resonance spectroscopy of native and recombined lipoproteins. Proc Natl Acad Sci U S A 1974 0.84
158 13C nuclear magnetic resonance spectroscopy of native and recombined lipoproteins. Proc Natl Acad Sci U S A 1974 0.84
159 Isolation of human serum HDL1 by zonal ultracentrifugation. J Lipid Res 1982 0.84
160 Measuring cholesterol in macrophages: comparison of high-performance liquid chromatography and gas-liquid chromatography with enzymatic fluorometry. Anal Biochem 1997 0.84
161 The relation of interleukin-6, tumor necrosis factor-alpha, IL-2, and IL-2 receptor levels to cellular rejection, allograft dysfunction, and clinical events early after cardiac transplantation. Transplantation 1995 0.84
162 Characterization of five new mutants in the carboxyl-terminal domain of human apolipoprotein E: no cosegregation with severe hyperlipidemia. Am J Hum Genet 1993 0.84
163 Changes in hemostasis during treatment of hypertriglyceridemia with a diet rich in monounsaturated and n-3 polyunsaturated fatty acids in comparison with a low-fat diet. Thromb Res 2001 0.84
164 Severe polyneuropathy in Tangier disease mimicking syringomyelia or leprosy. Clinical, biochemical, electrophysiological, and morphological evaluation, including electron microscopy of nerve, muscle, and skin biopsies. J Neurol 1985 0.84
165 Interleukin-6 correlates with hemodynamic impairment during dobutamine administration in chronic heart failure. Int J Cardiol 1996 0.84
166 A quantitative densitometric method for the rapid separation and quantitation of the major lipids of tissues and lipoproteins by high-performance thin-layer chromatography. II. Reduction of the densitometric data. J Chromatogr 1984 0.84
167 Incidence and risk factors for stroke in an occupational cohort: the PROCAM Study. Prospective Cardiovascular Muenster Study. Stroke 1998 0.84
168 Severe type III hyperlipoproteinemia associated with unusual apolipoprotein E1 phenotype and epsilon 1/'null' genotype. Eur J Clin Invest 1992 0.84
169 Abnormal lecithin:cholesterol acyltransferase activation by a human apolipoprotein A-I variant in which a single lysine residue is deleted. J Biol Chem 1984 0.84
170 The Prospective Cardiovascular Münster Study: prevalence and prognostic significance of hyperlipidemia in men with systemic hypertension. Am J Cardiol 1987 0.83
171 Fibrinogen and cardiovascular risk. J Cardiovasc Risk 1995 0.83
172 Apolipoprotein A-I (R151C)Paris is defective in activation of lecithin: cholesterol acyltransferase but not in initial lipid binding, formation of reconstituted lipoproteins, or promotion of cholesterol efflux. J Mol Med (Berl) 1999 0.83
173 [Accuracy of HDL-cholesterol and HDL-apolipoprotein A-I determinations after phosphotungstate/MgCl2-precipitation of apolipoprotein B-containing lipoproteins (author's transl)]. J Clin Chem Clin Biochem 1981 0.83
174 Normolipemic dysbetalipoproteinemia and hyperlipoproteinemia type III in subjects homozygous for a rare genetic apolipoprotein E variant (apoE1). J Lipid Res 1990 0.83
175 Coagulation factors and the progress of coronary heart disease. Lancet 1987 0.83
176 High risk strategies for atherosclerosis. Clin Chim Acta 1999 0.83
177 Metabolism of sphingosine bases, 18. Degradation in vitro of phytosphingosine (4d-hydroxysphinganine). Hoppe Seylers Z Physiol Chem 1972 0.83
178 A novel variant of lysosomal acid lipase (Leu336-->Pro) associated with acid lipase deficiency and cholesterol ester storage disease. Arterioscler Thromb Vasc Biol 1995 0.83
179 Effect of 10 weeks endurance training on the concentration of lipids and lipoproteins as well as on the composition of high-density lipoproteins in blood serum. Int J Sports Med 1983 0.83
180 High performance liquid chromatography and time-of-flight secondary ion mass spectrometry: a new dimension in structural analysis of apolipoproteins. J Lipid Res 1986 0.83
181 Flow-cytometric determination of high-density-lipoprotein binding sites on human leukocytes. Clin Chem 1987 0.83
182 Apolipoprotein A-IV polymorphism in man. Hum Genet 1982 0.83
183 Safety and tolerability of prolonged-release nicotinic acid in statin-treated patients. Curr Med Res Opin 2007 0.82
184 Defective regulation of phosphatidylcholine-specific phospholipases C and D in a kindred with Tangier disease. Evidence for the involvement of phosphatidylcholine breakdown in HDL-mediated cholesterol efflux mechanisms. J Clin Invest 1996 0.82
185 Positional specificity of triglyceride lipases in post-heparin plasma. J Biol Chem 1973 0.82
186 Phosphatidylcholine substrate specificity of lecithin:cholesterol acyltransferase. Scand J Clin Lab Invest Suppl 1978 0.82
187 Effects of diets containing olive oil, sunflower oil, or rapeseed oil on the hemostatic system. Thromb Haemost 2001 0.82
188 Nonsynonymous polymorphic sites in the apolipoprotein (apo) A-IV gene are associated with changes in the concentration of apo B- and apo A-I-containing lipoproteins in a normal population. Am J Hum Genet 1992 0.82
189 Smith-Lemli-Opitz syndrome diagnosed by using time-of-flight secondary-ion mass spectrometry. Clin Chem 1995 0.82
190 Structure and chromosomal assignment of the murine sterol carrier protein 2 gene (Scp2) and two related pseudogenes by in situ hybridization. Cytogenet Cell Genet 1996 0.82
191 Comparative effects of a recommended lipid-lowering diet vs a diet rich in monounsaturated fatty acids on serum lipid profiles in healthy young adults. Am J Clin Nutr 1992 0.82
192 Compound heterozygosity for a known and a novel defect in the lipoprotein lipase gene (Asp250-->Asn; Ser251-->Cys) resulting in lipoprotein lipase (LPL) deficiency. Neth J Med 1996 0.81
193 Detection of missense mutations in the genes for lipoprotein lipase and hepatic triglyceride lipase in patients with dyslipidemia undergoing coronary angiography. Atherosclerosis 2000 0.81
194 Dose-response relationships of serum lipid measurements with the extent of coronary stenosis. Strong, independent, and comprehensive. ECAT Angina Pectoris Study Group. Arterioscler Thromb Vasc Biol 1995 0.81
195 Cloning, expression and sequences of mouse sterol-carrier protein-x-encoding cDNAs and a related pseudogene. Gene 1993 0.81
196 [Pleomorphic functions of highly unsaturated phospholipids in biological membranes and serum lipoproteins]. Med Welt 1978 0.81
197 Phosphatidylcholine-specific phospholipase C regulates thapsigargin-induced calcium influx in human lymphocytes. J Biol Chem 1997 0.81
198 In vitro interaction of human HDL with human apolipoprotein A-II. Synthesis of apolipoprotein A-II-rich HDL. Biochim Biophys Acta 1981 0.81
199 Short-term prognostic value of lipid measurements in patients with angina pectoris. The ECAT Angina Pectoris Study Group: European Concerted Action on Thrombosis and Disabilities. Thromb Haemost 2000 0.81
200 [Penetration of penicillin G and ampicillin into mice fibroblasts (Earle's strain L). Effects of temperature and serum content of culture media]. Z Med Mikrobiol Immunol 1966 0.81
201 An immunological enrichment method for epithelial cells from peripheral blood. J Immunol Methods 1995 0.81
202 Interleukin-10 promoter microsatellite polymorphisms in systemic lupus erythematosus: association with the anti-Sm immune response. Rheumatology (Oxford) 2004 0.81
203 [Current diagnosis of hyperlipidemias]. Internist (Berl) 1979 0.80
204 Phase II trial of cyclophosphamide, leucovorin, 5-fluorouracil 24-hour infusion and tamoxifen in pancreatic cancer. J Exp Clin Cancer Res 2000 0.80
205 Characterization of atherosclerosis in a patient with familial high-density lipoprotein deficiency. Atherosclerosis 1994 0.80
206 Treatment of hypertriglyceridemia by two diets rich either in unsaturated fatty acids or in carbohydrates: effects on lipoprotein subclasses, lipolytic enzymes, lipid transfer proteins, insulin and leptin. Int J Obes Relat Metab Disord 2000 0.80
207 Lipoproteins and cardiovascular risk-from genetics to CHD prevention. J Atheroscler Thromb 1997 0.80
208 Analytical capillary isotachophoresis: a routine technique for the analysis of lipoproteins and lipoprotein subfractions in whole serum. J Chromatogr 1985 0.80
209 Multiple dysfunctions of two apolipoprotein A-I variants, apoA-I(R160L)Oslo and apoA-I(P165R), that are associated with hypoalphalipoproteinemia in heterozygous carriers. J Lipid Res 1999 0.80
210 [Prediction and early diagnosis of coronary disease. Prospective epidemiologic study of industrial workers in Westphalia]. Internist (Berl) 1980 0.80
211 Heterozygous hepatic lipase deficiency, due to two missense mutations R186H and L334F, in the HL gene. Atherosclerosis 1997 0.80
212 Detection of the metastatic potential of blood-borne and immunomagnetically enriched epithelial cells by quantitative erbB-2 RT-PCR. Clin Exp Metastasis 1996 0.80
213 NcoI RFLP at the human apolipoprotein CII gene locus. Nucleic Acids Res 1986 0.80
214 Accumulation of oxygenated steryl esters in Wolman's disease. J Lipid Res 1975 0.80
215 Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med 1997 0.80
216 Structural and functional properties of reconstituted high density lipoprotein discs prepared with six apolipoprotein A-I variants. J Lipid Res 1991 0.80
217 Diagnosis and management of new cardiovascular risk factors. Eur Heart J 1998 0.80
218 [The enzymatic analysis of sphingomyelin in HDL (author's transl)]. J Clin Chem Clin Biochem 1982 0.80
219 Characterization of very low density lipoproteins and intermediate density lipoproteins of normo- and hyperlipidemic apolipoprotein E-2 homozygotes. J Lipid Res 1985 0.80
220 Molecular basis of lipoprotein lipase deficiency in two Austrian families with type I hyperlipoproteinemia. Atherosclerosis 1991 0.80
221 Heterozygosity for apolipoprotein A-I(R160L)Oslo is associated with low levels of high density lipoprotein cholesterol and HDL-subclass LpA-I/A-II but normal levels of HDL-subclass LpA-I. J Lipid Res 1997 0.80
222 On the metabolism of sphinganyl- and sphingenyl-1-phosphorylcholine. Hoppe Seylers Z Physiol Chem 1972 0.80
223 Mutation in the factor V gene and the risk of myocardial infarction. N Engl J Med 1995 0.80
224 Genetic (primary) forms of hypertriglyceridemia. Am J Cardiol 1991 0.79
225 Comparison of risk factors for coronary heart disease in Dresden and Münster. Results of the DRECAN (Dresden Cardiovascular Risk and Nutrition) study and the PROCAM (Prospective Cardiovascular Münster) Study. Eur J Epidemiol 1994 0.79
226 Dimorphic markers for the human apolipoprotein CII gene locus. Gene 1987 0.79
227 HDL3 stimulates multiple signaling pathways in human skin fibroblasts. Arterioscler Thromb Vasc Biol 1995 0.79
228 Lipoproteins containing apolipoprotein A-IV but not apolipoprotein A-I take up and esterify cell-derived cholesterol in plasma. Arterioscler Thromb Vasc Biol 1995 0.79
229 Epidemiological study on factor VII, factor VIII and fibrinogen in an industrial population--II. Baseline data on the relation to blood pressure, blood glucose, uric acid, and lipid fractions. Thromb Haemost 1985 0.79
230 Human apolipoprotein CI (ApoC1) gene locus: BglI dimorphic site. Nucleic Acids Res 1987 0.79
231 PCR-based strategy for the diagnosis of hereditary neuropathy with liability to pressure palsies and Charcot-Marie-Tooth disease type 1A. Neurology 1998 0.79
232 Generation of pre-beta 1-HDL and conversion into alpha-HDL. Evidence for disturbed HDL conversion in Tangier disease. Arterioscler Thromb Vasc Biol 1995 0.79
233 Increased risk of myocardial infarction in men with both hypertriglyceridemia and elevated HDL cholesterol. Circulation 1999 0.79
234 Differential effects of lovastatin on the trafficking of endogenous and lipoprotein-derived cholesterol in human monocyte-derived macrophages. Arterioscler Thromb Vasc Biol 1998 0.79
235 A nonsense mutation in the apolipoprotein A-I gene is associated with high-density lipoprotein deficiency and periorbital xanthelasmas. Arterioscler Thromb 1994 0.79
236 Characterization of an apolipoprotein C-III mutant by high-performance liquid chromatography and time-of-flight secondary ion mass spectrometry. J Chromatogr 1987 0.79
237 Lipoproteins and apolipoproteins in the prediction of coronary artery disease. Acta Med Scand Suppl 1987 0.79
238 Prognostic relevance of aberrations in the erbB oncogenes from breast, ovarian, oral and lung cancers: double-differential polymerase chain reaction (ddPCR) for clinical diagnosis. Gene 1995 0.79
239 Immunologic effects of implantation of left ventricular assist devices. Transplant Proc 2001 0.79
240 Detection of apolipoprotein E variants by an oligonucleotide "melting" procedure. Clin Chem 1986 0.79
241 Effects of genotype and diet on cholesterol efflux into plasma and lipoproteins of normal, apolipoprotein A-I-, and apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 1997 0.79
242 Accumulation of RhoA, RhoB, RhoG, and Rac1 in fibroblasts from Tangier disease subjects suggests a regulatory role of Rho family proteins in cholesterol efflux. Biochem Biophys Res Commun 2001 0.79
243 Molecular genetics of arrhythmias--a new paradigm. Z Kardiol 2000 0.79
244 Erectile dysfunction as a risk factor for coronary heart disease: implications for prevention. Int J Clin Pract 2007 0.79
245 Displacement of the human apoprotein A-I by the human apoprotein A-II from complexes of (apoprotein A-I)-phosphatidylcholine-cholesterol. Eur J Biochem 1981 0.79
246 Properties of olive oil. Lancet 2001 0.79
247 The biologic lower detection limit of six ultrasensitive PSA assays. Anticancer Res 1999 0.78
248 The role of lecithin: cholesterol acyltransferase in high density lipoprotein3/high density lipoprotein2 interconversion. Clin Chim Acta 1982 0.78
249 The relationship of HDL-apolipoprotein A-I and HDL-Cholesterol to risk factors of coronary heart disease: initial results of the prospective epidemiological study in company employees in Westfalia. J Clin Chem Clin Biochem 1982 0.78
250 Interaction of reconstituted high density lipoprotein discs containing human apolipoprotein A-I (ApoA-I) variants with murine adipocytes and macrophages. Evidence for reduced cholesterol efflux promotion by apoA-I(Pro165-->Arg). J Biol Chem 1993 0.78
251 DraI RFLP in the human apolipoprotein AI-CIII-AIV gene complex. Nucleic Acids Res 1986 0.78
252 [Quantification of immunohistochemical expression of somatostatin receptors in neuroendocrine tumors using 68Ga-DOTATATE PET/CT]. Radiologe 2010 0.78
253 An economical assay for HDL phosphatidyl choline. J Clin Chem Clin Biochem 1983 0.78
254 Genetics of toll like receptor 9 in ANCA associated vasculitides. Ann Rheum Dis 2013 0.78
255 Changes of plasma lipids and lipoprotein levels during danazol treatment for endometriosis. Horm Metab Res 1984 0.78
256 Phase II trial of low-dose cyclophosphamide, leucovorin, high-dose 5-fluorouracil 24-hour continuous infusion and tamoxifen in advanced biliary tract cancer. Ann Oncol 2000 0.78
257 Immunophenotyping of lymphocytes obtained by bronchoalveolar lavage: description of an all-purpose tricolor flow cytometric application. J Immunol Methods 1996 0.78
258 Clinical value of electrocardiographic parameters in genotyped individuals with familial long QT syndrome. Pacing Clin Electrophysiol 2001 0.78
259 Modulated serum activities and concentrations of paraoxonase in high density lipoprotein deficiency states. Atherosclerosis 1998 0.78
260 Screening for naturally occurring apolipoprotein A-I variants: apo A-I(delta K107) is associated with low HDL-cholesterol levels in men but not in women. Hum Genet 1995 0.78
261 Isoproteins of human apolipoprotein A-II: isolation and characterization. J Lipid Res 1983 0.78
262 Effects of two kinds of decaffeinated coffee on serum lipid profiles in healthy young adults. Eur J Clin Nutr 1994 0.78
263 Structural and functional properties of natural and chemical variants of apolipoprotein A-I. Biochim Biophys Acta 1993 0.78
264 [HPV-associated oropharyngeal carcinoma. Status quo and relationship with cancer of unknown primary]. Pathologe 2014 0.77
265 Diadenosine polyphosphates induce transplasma membrane calcium influx in cultured glomerular mesangial cells. Eur J Clin Invest 1996 0.77
266 Associations of HDL phospholipids and paraoxonase activity with coronary heart disease in postmenopausal women. Acta Physiol Scand 2002 0.77
267 Impact of polymorphisms in the alpha- and beta-fibrinogen gene on plasma fibrinogen concentrations of coronary heart disease patients. Thromb Res 1995 0.77
268 Association of serum apolipoprotein A-I (but not high-density lipoprotein cholesterol) with healed myocardial infarction in men independent of serum insulin and C-peptide. Am J Cardiol 2001 0.77
269 Preparation of high-density lipoproteins labelled exclusively at the cholesteryl ester moiety. Clin Chim Acta 1982 0.77
270 High density lipoproteins enhance the Na+/H+ antiport in human platelets. Thromb Haemost 1996 0.77
271 Swollen joint count in psoriatic arthritis is associated with progressive radiological damage in hands and feet. Clin Exp Rheumatol 2012 0.77
272 Reassembly of human apoproteins A-I and A-II with unilamellar phosphatidylcholine-cholesterol liposomes. Association kinetics and characterization of the complexes. Biochim Biophys Acta 1980 0.77
273 Depletion of pre beta 1LpA1 and LpA4 particles by mast cell chymase reduces cholesterol efflux from macrophage foam cells induced by plasma. Arterioscler Thromb Vasc Biol 1999 0.77
274 Lipoprotein and apoprotein values in coronary angiography patients. Artery 1980 0.77
275 Dissociation of apolipoprotein AI from apoprotein-lipid complexes and from high-density lipoproteins. A fluorescence study. Eur J Biochem 1982 0.77
276 Raised lipoprotein(a) in hypercholesterolaemic black students compared to age-matched whites in North and South Carolina. Int J Epidemiol 1994 0.77
277 Effects of testosterone suppression in young men by the gonadotropin releasing hormone antagonist cetrorelix on plasma lipids, lipolytic enzymes, lipid transfer proteins, insulin, and leptin. Exp Clin Endocrinol Diabetes 1999 0.77
278 Metabolism of sphingosine bases. XVII. Stereospecificities in the introduction of the 4t-double bond into sphinganine yielding 4t-sphingenine (sphingosine). Hoppe Seylers Z Physiol Chem 1971 0.77
279 Elecsys TSH, FT4, T4, T-uptake, FT3 and T3. Clinical results of a multicentre study. Wien Klin Wochenschr 1998 0.77
280 A natural apolipoprotein A-I variant, apoA-I (L141R)Pisa, interferes with the formation of alpha-high density lipoproteins (HDL) but not with the formation of pre beta 1-HDL and influences efflux of cholesterol into plasma. J Lipid Res 1997 0.77
281 Single cell analysis of B lymphocytes from Wegener's granulomatosis: B cell receptors display affinity maturation within the granulomatous lesions. Clin Exp Immunol 2008 0.77
282 Mannitol prevents methionine sulphoxidation mediated electrophoretic heterogeneity of apolipoprotein A-I. Biomed Chromatogr 1995 0.77
283 Plasminogen activator inhibitor-1 4G/5G-polymorphism and factor V Q506 mutation are not associated with myocardial infarction in young men. Blood Coagul Fibrinolysis 1998 0.77
284 [HDL cholesterol: biochemical aspects (author's transl)]. Klin Wochenschr 1980 0.77
285 Lipid binding properties of the Tangier apolipoprotein A-I and its isoproteins. J Lipid Res 1984 0.77
286 The influence of a 100 km run on the composition of HDL. J Clin Chem Clin Biochem 1982 0.77
287 [Strategy for the prevention of ischemic heart disease. Directives from the European Society of Atherosclerosis]. Rev Esp Cardiol 1987 0.77
288 Pvu II RFLP in the 5' of the human apolipoprotein B gene. Nucleic Acids Res 1986 0.77
289 The transforming growth factor-beta1 gene polymorphism (G915C) is not associated with systemic lupus erythematosus. Lupus 2003 0.76
290 Involvement of phospholipase D in store-operated calcium influx in vascular smooth muscle cells. FEBS Lett 2000 0.76
291 Downregulation of the selectin ligand-producing fucosyltransferases Fuc-TIV and Fuc-TVII during foam cell formation in monocyte-derived macrophages. Arterioscler Thromb Vasc Biol 1997 0.76
292 Deficiency of lecithin:cholesterol acyltransferase due to compound heterozygosity of two novel mutations (Gly33Arg and 30 bp ins) in the LCAT gene. Hum Mol Genet 1995 0.76
293 Stability and binding properties of wild-type and c17s mutated human sterol carrier protein 2. Biochim Biophys Acta 1999 0.76
294 Diadenosine polyphosphates regulate cytosolic calcium in human fibroblast cells by interaction with P2x purinoceptors coupled to phospholipase C. Biochim Biophys Acta 1996 0.76
295 Lipid-free apolipoprotein (apo) A-I is converted into alpha-migrating high density lipoproteins by lipoprotein-depleted plasma of normolipidemic donors and apo A-I-deficient patients but not of Tangier disease patients. Atherosclerosis 1998 0.76
296 Interaction of Tangier lipoproteins with cholesteryl ester-laden mouse peritoneal macrophages. J Lipid Res 1987 0.76
297 Na(+)/Ca(2+) exchange inhibitors modulate thapsigargin-induced Ca(2+) and Na(+) influx in human lymphocytes. Int J Clin Lab Res 1999 0.76
298 HDL3 activates phospholipase D in normal but not in glycoprotein IIb/IIIa-deficient platelets. Biochem Biophys Res Commun 1995 0.76
299 Effects of a frequent apolipoprotein E isoform, ApoE4Freiburg (Leu28-->Pro), on lipoproteins and the prevalence of coronary artery disease in whites. Arterioscler Thromb Vasc Biol 1999 0.76
300 Demonstration of human apolipoprotien A in isolated mucosal cells from small intestine and isolated hepatocytes. Gut 1979 0.76
301 In vivo kinetics of human apolipoprotein A-I variants in rabbits. Eur J Clin Invest 1999 0.76
302 Basal growth hormone levels in women are positively correlated with high-density lipoprotein cholesterol and apolipoprotein A-I independently of insulin-like growth factor 1 or insulin. Metabolism 1998 0.76
303 Complete deficiency of plasma lecithin-cholesterol acyltransferase (LCAT) activity due to a novel homozygous mutation (Gly-30-Ser) in the LCAT gene. Hum Mutat 1996 0.76
304 Diagnosis of Smith-Lemli-Opitz syndrome. N Engl J Med 1994 0.75
305 Avoidance of false positives in PCR-based mRNA differential display during investigation of nonstandardized tissues or cells. Clin Chem 1997 0.75
306 [Comparison of international recommendations for the recognition of asymptomatic high risk patients for a heart attack in Germany]. Z Kardiol 2005 0.75
307 ECG repolarization patterns in chromosome 7-linked QT syndrome (LQTS 2) Circulation 1996 0.75
308 HDL sphingomyelin determinations in normal individuals and patients with type IV-hyperlipoproteinaemia. J Clin Chem Clin Biochem 1983 0.75
309 No deception in symposium supplement. BMJ 1994 0.75
310 Factor V Leiden and thromboembolism. Circulation 1998 0.75
311 The significance of high-density lipoproteins (HDL) in the clearance of intravenously administered bacterial lipopolysaccharides (LPS) in mice. Hepatogastroenterology 1988 0.75
312 Absence of mutations in peripheral myelin protein-22, myelin protein zero, and connexin 32 in autosomal recessive Dejerine-Sottas syndrome. Neurosci Lett 1998 0.75
313 The role of PPAR alpha in obesity. Nutr Metab Cardiovasc Dis 2001 0.75
314 Lowering of HDL cholesterol in post-menopausal women by tibolone is not associated with changes in cholesterol efflux capacity or paraoxonase activity. Atherosclerosis 2001 0.75
315 Marked changes of lipid levels during puberty in a patient with lipoprotein lipase deficiency. Eur J Pediatr 1997 0.75
316 [Clinical aspects and molecular genetics of the Jervell- and Lange-Nielsen Syndrome]. Z Kardiol 2002 0.75
317 Hypochromic red cells and reticulocyte haemglobin content as markers of iron-deficient erythropoiesis in patients undergoing chronic haemodialysis. Nephrol Dial Transplant 1999 0.75
318 Coronary heart disease prevention task force. Eur Heart J 1999 0.75
319 Strategies for the assessment of genetic coronary artery disease risk. Curr Opin Lipidol 1999 0.75
320 Panel discussion. II: Objectives of basic research and predictive value preclinical testing. Arzneimittelforschung 1989 0.75
321 A novel system to test for specificity of B cell receptors from tissue of Wegener's granulomatosis patients. Clin Exp Rheumatol 2008 0.75
322 Mutational analysis of two frequently observed lipoprotein lipase gene variants in the Japanese population. J Inherit Metab Dis 1997 0.75
323 Translational research studies of erbB oncogenes: selection strategies for breast cancer treatment. Cancer Lett 1997 0.75
324 [Detection and treatment of lipid disorders]. Rev Clin Esp 1988 0.75
325 Functional foods and cardiometabolic diseases* International Task Force for Prevention of Cardiometabolic Diseases. Nutr Metab Cardiovasc Dis 2014 0.75
326 [Cholesteryl ester storage disease in the liver (author's transl)]. Leber Magen Darm 1981 0.75
327 [The tumor marker CA 15-3 in breast cancer in serum and cell compartments as an additional prognostic criterion]. Geburtshilfe Frauenheilkd 1988 0.75
328 Effect of acute treatment with cadmium on ethanol anesthesia, body temperature, and synaptosomal Na+-K+-ATPase of rat brain. Environ Res 1981 0.75
329 Pravastatin and coronary heart disease. Circulation 1999 0.75
330 The hypertriglyceridemias: risk and management. Introduction. Am J Cardiol 1991 0.75
331 [Risk factor calculator for medical underwriting of life insurers based on the PROCAM study]. Versicherungsmedizin 2008 0.75
332 Digoxinlike immunoreactive substance in critically ill patients. Anesthesiology 1994 0.75
333 [Improved diagnosis of hyperlipidemia by including HDL cholesterol]. Lebensversicher Med 1986 0.75
334 Effect of hypertriglyceridaemia on lipoprotein (a) serum concentrations. Eur J Clin Invest 1995 0.75
335 Use of longer extension phases to improve yield of high molecular weight products in differential display PCR. Clin Chim Acta 2000 0.75
336 Glutamine/histidine polymorphism in apo A-IV affects plasma concentrations of lipoprotein(a) and fibrin split products in coronary heart disease patients. Arterioscler Thromb 1993 0.75
337 [The detection of apolipoproteins AI and B in the liver of patients with and without hyperlipoproteinemia (author's transl)]. Z Gastroenterol 1981 0.75
338 High density lipoproteins and reverse cholesterol transport: lessons from mutations. Atherosclerosis 1998 0.75
339 Phospholipase A(2) is involved in thapsigargin-induced sodium influx in human lymphocytes. Arch Biochem Biophys 2000 0.75
340 Sex-specific effects of the glutamine/histidine polymorphism in apo A-IV on HDL metabolism. Arterioscler Thromb 1994 0.75
341 Cholesterol efflux from normal and Tangier disease fibroblasts into normal, high-density lipoprotein-deficient, and apolipoprotein E-deficient plasmas. Metabolism 2000 0.75
342 [Non-pharmacologic treatment of hyperlipemia: diet and exercise]. Rev Clin Esp 1990 0.75
343 Detection of a new Msp I restriction fragment length polymorphism in the apolipoprotein A-I gene. J Clin Chem Clin Biochem 1987 0.75
344 [Cushing's syndrome with bilateral nodular adrenal enlargement]. Internist (Berl) 2007 0.75
345 [Candidate selected method for the enzymatic determination of total cholesterol in serum]. J Clin Chem Clin Biochem 1983 0.75
346 Special investigations on the differential diagnosis of FAT metabolism disorders. Przegl Lek 1989 0.75
347 [Performance and limitations of the analysis of HDL-cholesterol (author's transl)]. J Clin Chem Clin Biochem 1981 0.75
348 Influence of triglyceride-rich lipoproteins on nephelometry of apolipoprotein A-I. Clin Chem 1982 0.75
349 Transforming growth factor beta and coronary artery disease. Nutr Metab Cardiovasc Dis 2000 0.75
350 Apolipoprotein A-I (Glu 198----Lys): a mutant of the major apolipoprotein of high-density lipoproteins occurring in a family with dyslipoproteinemia. Pediatr Res 1988 0.75
351 Investigation of the performance of the ES 600 Enzymun-Test system. A multicentre study. J Clin Chem Clin Biochem 1988 0.75
352 High-density lipoproteins inhibit fibrinogen binding on adenosine diphosphate-activated monocytes. Blood Coagul Fibrinolysis 2000 0.75
353 Prevention of coronary heart disease in post-menopausal women. Nutr Metab Cardiovasc Dis 2000 0.75
354 Predictive value of the CD45RO positive T-helper lymphocyte subset for acute cellular rejection during the early phase after kidney transplantation. Transplant Proc 1999 0.75
355 [HDL cholesterol profile in 1988]. Rev Clin Esp 1989 0.75
356 [The importance of HDL-cholesterol as a risk factor in coronary artery disease]. Internist (Berl) 1980 0.75
357 [Homocysteine and atherogenesis]. Internist (Berl) 1998 0.75
358 Basal growth hormone levels are positively correlated with high-density lipoprotein cholesterol levels in women. Metabolism 1997 0.75
359 Determination of LDL cholesterol and LDL apolipoprotein B following precipitation of VLDL in blood serum with phosphotungstic acid/MgCl2. J Clin Chem Clin Biochem 1984 0.75
360 Frequency of apolipoprotein A-I mutants in the German population. J Clin Chem Clin Biochem 1984 0.75
361 [Coronary angiography and intravascular ultrasound examination of a 60-year-old patient with familial HDL deficiency (Tangier disease)]. Z Kardiol 1994 0.75
362 Round table discussion: practical issues in the management of dyslipidaemic patients. Atherosclerosis 1996 0.75
363 Effect of antihypertensive drugs on cellular cholesterol metabolism: a challenge for further research. J Cardiovasc Pharmacol 1986 0.75
364 HDL apolipoprotein A-I and HDL apolipoprotein A-II concentrations in male company employees in Westphalia aged 40 years and older. J Clin Chem Clin Biochem 1986 0.75
365 Observations of HDL components in female probands following an ultra-long distance run of 100 miles. J Clin Chem Clin Biochem 1985 0.75
366 Dietary habits in Eastern Germany: changes after reunification and their relation to CHD risk profiles (DRECAN). Rev Environ Health 1996 0.75
367 [The diagnosis of hyperlipidemias (author's transl)]. Ther Umsch 1980 0.75
368 Uptake, transfer, and esterification of cell-derived cholesterol in plasma of patients with familial HDL-deficiency. Z Gastroenterol 1996 0.75
369 [Results of the "Munster Prospective Cardiovascular" study]. Soz Praventivmed 1988 0.75
370 [Determine the cholesterol level early. Interview with Prof. G. Assmann, Munster]. Fortschr Med Suppl 1988 0.75
371 [Clinical aspects and molecular genetics of the long QT-syndrome]. Dtsch Med Wochenschr 1999 0.75
372 [HDL cholesterol: clinical and pathobiochemical aspects (author's transl)]. Klin Wochenschr 1980 0.75
373 Role of the high density lipoprotein-receptor cycle in macrophage-cholesterol metabolism. Klin Wochenschr 1986 0.75
374 Mineral oil enhances the autoradiographic detection of 32P-labeled nucleic acids bound to nitrocellulose membranes. Anal Biochem 1987 0.75
375 Competitive enzyme immunoassay for apolipoprotein A-II. J Clin Chem Clin Biochem 1983 0.75
376 Similar serum plant sterol responses of human subjects heterozygous for a mutation causing sitosterolemia and controls to diets enriched in plant sterols or stanols. Eur J Clin Nutr 2007 0.75
377 Compound heterozygosity for a known (D250N) and a novel (E410K) missense mutation in the C-terminal domain of lipoprotein lipase causes familial chylomicronemia. Hum Mutat 1996 0.75
378 [Recognizing patients at high risk for myocardial infarct]]. Praxis (Bern 1994) 2003 0.75
379 Cholesterol esterification by the rat liver Golgi apparatus. Scand J Clin Lab Invest Suppl 1974 0.75
380 Metabolism of sphinosine bases, XIX. On the origin of phytosphingosine (4d-hydroxysphinganine) in mammalian tissues. Hoppe Seylers Z Physiol Chem 1972 0.75
381 Electrophoretic screening for human apolipoprotein C-II variants: repeated identification of apolipoprotein C-II(K19T). J Mol Med (Berl) 1995 0.75
382 [A morphological and biochemical study in Niemann-Pick disease (author's transl)]. Verh Dtsch Ges Pathol 1976 0.75
383 [How does the rapid cholesterol tests work?]. Med Monatsschr Pharm 1991 0.75
384 Turbidimetric kinetic method for serum low density lipoprotein quantitation. Clin Chim Acta 1983 0.75
385 [Relationship between lipid metabolism disorders and age of first manifestations of coronary heart disease]. Z Kardiol 1992 0.75
386 [Lipid metabolism and risk of myocardial infarction -- new findings and implications for treatment]. Dtsch Med Wochenschr 2005 0.75
387 Lipoproteins and cardiovascular risk--from genetics to CHD prevention. Eur Heart J 1998 0.75
388 [The physiology of lipoprotein metabolism]. Infusionsther Klin Ernahr 1983 0.75
389 Results of the multicentre evaluation of an electrochemiluminescence immunoassay for HCG on Elecsys 2010. Wien Klin Wochenschr 1998 0.75
390 Clinical chemistry and coagulation. Curr Opin Lipidol 1994 0.75
391 Apolipoprotein B determination in the dissolved precipitate obtained after precipitation of LDL with polyvinylsulphate. An alternative method for the determination of LDL apolipoprotein B without using ultracentrifugation. J Clin Chem Clin Biochem 1986 0.75
392 VLDL apolipoprotein B determination in blood serum following precipitation of LDL with polyvinylsulphate. J Clin Chem Clin Biochem 1985 0.75
393 [Schwannoma of the nasal cavity: a case report]. HNO 2007 0.75
394 Characterization of glucuronidated phase II metabolites of the immunosuppressant cyclosporine in urine of transplant patients using time-of-flight secondary-ion mass spectrometry. Drug Metab Dispos 1996 0.75
395 A missense mutation (Thr-6Pro) in the lysosomal acid lipase (LAL) gene is present with a high frequency in three different ethnic populations: impact on serum lipoprotein concentrations. Hum Genet 1996 0.75
396 Genetically determined absence of HDL-cholesterol and coronary atherosclerosis. Lancet 1995 0.75
397 HDL phosphatidyl choline and cigarette smoking. Klin Wochenschr 1984 0.75
398 [Tangier-disease (author's transl)]. Klin Wochenschr 1979 0.75
399 Elevated low-density lipoprotein-cholesterol in women with polycystic ovary syndrome. Gynecol Endocrinol 1996 0.75
400 VLDL cholesterol and VLDL apolipoprotein B. Preliminary cross-sectional data of the prospective epidemiological study of company employees in Westphalia. J Clin Chem Clin Biochem 1987 0.75
401 Recurrent brachial plexus palsies as the only clinical expression of hereditary neuropathy with liability to pressure palsies associated with a de novo deletion of the peripheral myelin protein-22 gene. Muscle Nerve 1998 0.75
402 Determination of HDL phosphatidyl choline by an enzymatic method. J Clin Chem Clin Biochem 1983 0.75
403 D609-phosphatidylcholine-specific phospholipase C inhibitor attenuates thapsigargin-induced sodium influx in human lymphocytes. Cell Signal 2000 0.75
404 No apparent restriction on measuring FVIIa in frozen plasma. Thromb Haemost 1997 0.75
405 Primary prevention of coronary heart disease: from controversy to consensus. Nutr Metab Cardiovasc Dis 2000 0.75
406 Plasma lipoproteins and physical activity. Int J Sports Med 1982 0.75
407 [Gastroenterologic diagnosis of hypolipoproteinemias with special emphasis on Tangier disease]. Verh Dtsch Ges Inn Med 1978 0.75
408 Interaction of lipoproteins with macrophages. Haematol Blood Transfus 1981 0.75
409 Enzymology of lecithin:cholesterol acetyltransferase. Biochem Soc Trans 1985 0.75
410 The role of high density lipoproteins in lecithin:cholesterol acyltransferase activity: perspectives from Tangier disease. Scand J Clin Lab Invest Suppl 1978 0.75
411 Changes in HDL composition in female subjects following a 100-km run. Int J Sports Med 1984 0.75
412 [Transcriptome analyses in renal cell carcinoma. Combination of laser microdissection and microarrays]. Urologe A 2007 0.75
413 Precipitation of LDL with sulphopolyanions: a comparison of two methods for LDL cholesterol determination. J Clin Chem Clin Biochem 1984 0.75
414 Elecsys CEA, PSA and AFP. Clinical results of a multicentre evaluation. Wien Klin Wochenschr 1998 0.75
415 [Unified system of accounting and statistics in the veterinary profession]. Monatsh Veterinarmed 1970 0.75
416 The delayed effects of prolonged physical exercise and physical training on cholesterol level. Eur J Appl Physiol Occup Physiol 1982 0.75
417 [Apolipoproteinopathies]. Klin Wochenschr 1983 0.75
418 Apolipoprotein disorders. Ric Clin Lab 1982 0.75
419 [Women and ischemic cardiopathy]. Rev Clin Esp 1989 0.75
420 [Apolipoprotein E polymorphism, hyperlipidemia and risk of myocardial infarct]. Internist (Berl) 1985 0.75
421 Multicenter evaluation of Reflotron direct dry-chemistry assay of high-density lipoprotein cholesterol in venous and fingerstick specimens. Clin Chem 1993 0.75
422 [Behavior of lymphocytic lysosomes in cholesterol ester storage disease]. Acta Histochem Suppl 1983 0.75
423 Different substrate specificities of plasma lecithin: cholesterol acyl transferase in fish eye disease and Tangier disease. Acta Med Scand 1987 0.75
424 A new molecular defect in the lecithin: cholesterol acyltransferase (LCAT) gene associated with fish eye disease. J Lipid Res 1996 0.75
425 [Screening and therapy control of lipid metabolism disturbances in general practice (author's transl)]. MMW Munch Med Wochenschr 1980 0.75
426 Effect of polyenephosphatidylcholine on cholesterol uptake by human high density lipoprotein. Atherosclerosis 1981 0.75
427 Intrinsic sterol- and phosphatidylcholine transfer activities of 17 beta-hydroxysteroid dehydrogenase type IV. J Steroid Biochem Mol Biol 1995 0.75
428 Lipoproteins and apolipoprotein patterns in rat plasma after liver injury induced by D-galactosamine. Hoppe Seylers Z Physiol Chem 1980 0.75
429 Clinical implications of elevated lipoprotein(a). Curr Atheroscler Rep 2001 0.75
430 Determination of apolipoprotein B in apolipoprotein CII/CIII-containing lipoproteins by an immunoenzymmetric assay. Eur J Clin Chem Clin Biochem 1992 0.75
431 Specificity of the heparin-LDL interaction. Clin Chim Acta 1984 0.75
432 HDL phosphatidyl choline and risk-factors of coronary heart disease. J Clin Chem Clin Biochem 1984 0.75
433 Role of low-density and high-density lipoproteins in atherogenesis. Nutr Metab 1980 0.75
434 Plasma exchange in type II hypercholesterolemia. Prog Clin Biol Res 1988 0.75
435 Four frequently observed polymorphisms in the 3'-UTR of human peripheral myelin protein 22 (PMP22): identification of different haplotypes. Clin Genet 1996 0.75
436 [Use of risk factors in determining individual coronary risk]. Z Kardiol 2005 0.75
437 Turbidimetric assay of apolipoprotein A-II. J Clin Chem Clin Biochem 1985 0.75
438 [Diagnosis of hyperlipidemias]. Med Welt 1977 0.75
439 A novel missense mutation (Gly2Arg) in the human lysosomal acid lipase gene is found in individuals with and without cholesterol ester storage disease (CESD). Clin Genet 1996 0.75
440 [Sarcoidosis of lymph nodes in the submandibular compartment]. HNO 2010 0.75
441 Analytical procedures for the detection and characterization of apolipoprotein E mutants. Am Heart J 1987 0.75
442 Densitometry of phosphatidylcholine and sphingomyelin in high-density lipoproteins. Clin Chem 1983 0.75